Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.34M Buy
16,101
+1,250
+8% +$173K 0.18% 71
2026
Q2
$1.91M Sell
14,851
-330
-2% -$38.6K 0.16% 75
2026
Q1
$1.83M Buy
15,181
+48
+0.3% +$5.54K 0.16% 72
2025
Q4
$1.59M Buy
15,133
+299
+2% +$28.1K 0.13% 80
2025
Q3
$1.25M Buy
14,834
+120
+0.8% +$9.9K 0.1% 104
2025
Q2
$1.16M Sell
14,714
-669
-4% -$53.2K 0.11% 97
2025
Q1
$1.38M Sell
15,383
-1,590
-9% -$148K 0.13% 85
2024
Q4
$1.69M Sell
16,973
-6,656
-28% -$686K 0.12% 89
2024
Q3
$2.68M Buy
23,629
+4,258
+22% +$506K 0.2% 49
2024
Q2
$2.4M Buy
19,371
+123
+0.6% +$15.8K 0.19% 53
2024
Q1
$2.54M Sell
19,248
-1,383
-7% -$170K 0.2% 53
2023
Q4
$2.25M Buy
+20,631
New +$2.14M 0.19% 59

Other funds holding MRK

Trust Point's MRK Position: Q3 2026 in Review

Trust Point increased its Merck (MRK) stake by 8.4% in Q3 2026, buying an estimated $173K and bringing the position to 16,101 shares worth $2.34M. The position accounts for 0.18% of the portfolio, ranked #71.

Trust Point first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.68M in Q3 2024. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Trust Point held 16,101 shares of Merck worth $2.34M as of Q3 2026.
  • Trust Point bought 1,250 Merck shares in Q3 2026, an estimated $173K.
  • Merck made up 0.18% of Trust Point's portfolio in Q3 2026, its #71 holding.
  • Trust Point first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
  • Trust Point's Merck position peaked at $2.68M in Q3 2024.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.